Operating income before deduction of amortization: Trinity Biotech plc (TRIB)
The efficiency of Trinity Biotech plc (TRIB) is based on strict control over reagent supplies through pharmacy chains. Growth is driven by the implementation of CGM systems and new insurance codes in the US. However, debt load and slow scaling create liquidity shortage risks. The GURU.Markets portal features a chart of absolute EBITDA dynamics, where the current level is around 0.00, allowing for a real-time assessment of the cash result from core operations.
Summary analytical data breakdowns for Trinity Biotech (TRIB)
- market value and analyst target forecast:
- company stock exchange capitalization indicators:
- balance sheet equity data:
- business debt structure and liquidity details:
Aggregate Debt to Capital Trinity Biotech plc|TRIB - Long-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital Trinity Biotech PLC|TRIB - Company Aggregate Debts|Debts to Net Assets Trinity Biotech|TRIB - Company Long-Term Debt|Company Short-Term Indebtedness Trinity Biotech|Interim Coverage Ratio trinitybiotech.com
- company profitability and valuation multiples indicators:
TRIB - Net Income|Future Net Profit Trinity Biotech plc|TRIB - Price to Earnings Ratio|Projected Price to Earnings Ratio Trinity Biotech PLC|TRIB - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation Trinity Biotech|TRIB - Operating profit EBITDA|Earnings per share for the last twelve months Trinity Biotech|TRIB - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months trinitybiotech.com|TRIB - Earnings per share growth in current year|Expected net earnings per share growth next year Trinity Biotech plc
Summary company analytics:TRIB Trinity Biotech plc
This metric reflects the actual cash flow from the core operations of Trinity Biotech (TRIB), adjusted for depreciation and taxes, which confirms the monetization of long-term contracts within the diagnostics segment. By analyzing the EBITDA chronology, an investor can see the resilience of operating profit, supported by high barriers to entry and FDA/CE regulatory protection, allowing market volatility to be decoupled from the fundamental value of the business.
Competitors of Trinity Biotech plc (TRIB)
Agilent Corp (A) - Profit before interest, taxes and amortization|DGX - Profit before payment of interest, taxes and amortization|Operating income before deduction of amortization illumina.com ILMN|EXAS: Operating profit EBITDA|RVTY - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Bio-Rad Laboratories Inc|Anbio Corp (NNNN) - Operating income before deduction of amortization|Operating profit before deduction of amortization SHC (Sotera Health Company)|Company profit before taxes, interest and amortization QDEL|Profit before payment of interest, taxes and amortization OPKO Health OPK|Income before deduction of interest, taxes and amortization CDNA|Maravai LifeSciences Corp - Operating profit EBITDA|Operating income before deduction of amortization Fulgent FLGT|Standard BioTools Inc. (LAB) - Profit before payment of interest, taxes and amortization|Operating profit before amortization CTKB|OSUR (OraSure) - Operating profit EBITDA|Exagen Diagnostics (XGN) - Operating income before deduction of amortization|Operating profit before deduction of amortization MDXH (MDxHealth Inc.)|Company profit before taxes, interest and amortization LUCD|Prenetics - Operating profit before deduction of amortization|Insight Molecular Diagnostics, Inc. (IMDX) - Profit before interest, taxes and amortization|PRPH: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization AIMD (Ainos Inc)|CODX: Operating profit EBITDA|HSCS (Heart Test Labs) - Profit before payment of interest, taxes and amortization|BMRA (Biomerica, Inc.) - Operating profit EBITDA|Cardio Diagnostics Holdings, Inc. (CDIO) - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Onconetix (ONCO)|VRAX - Profit before interest, taxes and amortization|Bluejay - Operating profit before deduction of amortization|Company profit before taxes, interest and amortization AWH (Aspira Women's Health Inc)|Accelerate Diagnostics - Operating profit EBITDA|Profit before interest, taxes and amortization Centogene|ENZ: Operating profit EBITDA|Operating profit before deduction of amortization Fresh2 Group|GENE (Genetic Technologies Ltd) - Operating profit EBITDA|ME: Income before deduction of interest, taxes and amortization|Operating profit before deduction of amortization PMD (Psychemedics)
